<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6"><labelDrug name="PRINIVIL"><Normalization><mmtx cui="C0701176" preferredWord="Prinivil" semType="phsu, aapp"/></Normalization></labelDrug><generic name="lisinopril"/><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.1" text="PRINIVIL (lisinopril) tablet" type="negative"><entity charOffset="10:20" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.1.e.0" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="(lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.1.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.1.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.1.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2" text="PRINIVIL (Lisinopril), a synthetic peptide derivative, is an oral long-acting angiotensin converting enzyme inhibitor." type="negative"><entity charOffset="78:117" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="an oral long-acting angiotensin converting enzyme inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="10:20" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.2" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="(Lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.2.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.8" text="PRINIVIL is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema." type="negative"><entity charOffset="0:8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.8.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="162:201" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.8.e.1" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with an angiotensin converting enzyme inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.8.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.8.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9" lineNumber="14" text="Do not coadminister aliskiren with PRINIVIL in patients with diabetes." type="regular"><entity charOffset="20:29" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with PRINIVIL" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="0:19" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.3" text="Do not coadminister" type="SPAN"/><entity charOffset="35:43" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="aliskiren with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="61:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.5" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.5" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.4" severity="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.9.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12" text="Presumably because angiotensin converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including PRINIVIL) may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="193:201" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="19:59" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.2" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.12.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.13" text="Head and Neck Angioedema: Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin converting enzyme inhibitors, including PRINIVIL. " type="negative"><entity charOffset="142:182" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.13.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="194:202" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.13.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.13.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.13.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.17" text="Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. " type="negative"><entity charOffset="165:179" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.17.e.0" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0019590" phraseText="treatment with antihistamines" preferredWord="Histamine Antagonists" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><entity charOffset="184:199" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.17.e.1" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.17.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.17.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.26" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="129:137" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.26.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="142:155" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.26.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.26.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.26.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28" lineNumber="28" text="Anaphylactoid reactions during desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="177:200" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.0" text="anaphylactoid reactions" type="Specific_Interaction"/><entity charOffset="48:60" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.2" text="Two patients" type="SPAN"/><entity charOffset="101:118" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.3" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.4" evidence="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.2" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.28.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41" lineNumber="38" text="It may be advisable to eliminate the diuretic (except in patients with heart failure), reduce the diuretic dose or increase salt intake cautiously before initiating therapy with PRINIVIL in patients at risk for excessive hypotension who are able to tolerate such adjustments. " type="regular"><entity charOffset="23:32" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.0" text="eliminate" type="Caution_Interaction"/><entity charOffset="87:97|107:111" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.2" text="reduce the dose" type="Caution_Interaction"/><entity charOffset="37:45" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.4" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="98:106" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.5" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic dose" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:186" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.6" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="increase salt intake cautiously before initiating therapy with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="190:232" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.7" text="patients at risk for excessive hypotension" type="SPAN"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.0"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.ddi.2"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.2"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.6"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.7" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.4" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.6" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.0" type="Caution_Interaction"/><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.7" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.5" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.6" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.41.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.44" text="Treatment with PRINIVIL must not be initiated in acute myocardial infarction patients at risk of further serious hemodynamic deterioration after treatment with a vasodilator (e.g., systolic blood pressure of 100 mmHg or lower) or cardiogenic shock." type="negative"><entity charOffset="15:23" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.44.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="Treatment with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="162:173" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.44.e.1" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C3537240" phraseText="with a vasodilator" preferredWord="Vasodilator [EPC]" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.44.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.44.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45" lineNumber="42" text="In patients at risk of excessive hypotension, therapy should be started under very close medical supervision and such patients should be followed closely for the first two weeks of treatment and whenever the dose of PRINIVIL and/or diuretic is increased. " type="regular"><entity charOffset="137:153" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.0" text="followed closely" type="Caution_Interaction"/><entity charOffset="3:44" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.2" text="patients at risk of excessive hypotension" type="SPAN"/><entity charOffset="216:224" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.3" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="the dose of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="232:240" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.4" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.0"><relations><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.2" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.4" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.45.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49" lineNumber="44" text="If symptomatic hypotension develops, a dose reduction or discontinuation of PRINIVIL or concomitant diuretic may be necessary." type="regular"><entity charOffset="15:26" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="76:84" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.2" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="discontinuation of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="100:108" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitant diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.49.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.51" text="Another angiotensin converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients but more frequently in patients with renal impairment especially if they also have a collagen vascular disease. " type="negative"><entity charOffset="49:58" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.51.e.0" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="8:47" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.51.e.1" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="Another angiotensin converting enzyme inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.51.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.51.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.56" text="Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice or hepatitis and progresses to fulminant hepatic necrosis, and (sometimes) death. " type="negative"><entity charOffset="8:22" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.56.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.56.e.1" text="hepatitis" type="Biomedical_Entity"><Normalization><mmtx cui="C0795623" phraseText="hepatitis" preferredWord="Hepatitis A Vaccine, Inactivated" semType="phsu, imft"/><RxNorm RxCui="989819"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.56.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.56.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="198:221" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.66.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.78" text="Aortic Stenosis/Hypertrophic Cardiomyopathy: As with all vasodilators, lisinopril should be given with caution to patients with obstruction in the outflow tract of the left ventricle." type="negative"><entity charOffset="57:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.78.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="As with all vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="71:81" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.78.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.78.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.78.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.79" text="Impaired Renal Function: As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="66:77" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.79.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.79.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.79.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.79.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80" text="In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin converting enzyme inhibitors, including PRINIVIL, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death." type="negative"><entity charOffset="157:197" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="122:133" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="110:121" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="209:217" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.3" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL," preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.3"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.3"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.80.e.3"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82" text="Experience with another angiotensin converting enzyme inhibitor suggests that these increases are usually reversible upon discontinuation of PRINIVIL and/or diuretic therapy. " type="negative"><entity charOffset="24:63" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.0" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="Experience with another angiotensin converting enzyme inhibitor" preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="141:149" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="usually reversible upon discontinuation of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="157:165" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.2" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.2"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.82.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84" lineNumber="74" text="Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when PRINIVIL has been given concomitantly with a diuretic. " type="regular"><entity charOffset="117:126|130:149|154:170" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.0" text="increases blood urea nitrogen serum creatinine" type="Specific_Interaction"/><entity charOffset="217:225" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.2" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="262:270" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.84.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.86" text="Dosage reduction and/or discontinuation of the diuretic and/or PRINIVIL may be required." type="negative"><entity charOffset="47:55" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.86.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.86.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.86.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.86.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95" lineNumber="80" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. " type="irregular"><entity charOffset="36:48" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="124:151" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes." preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.89" text="If renal dysfunction develops during treatment with PRINIVIL (serum creatinine concentration exceeding 3 mg/dL or a doubling from the pre-treatment value) then the physician should consider withdrawal of PRINIVIL."><entity charOffset="204:212" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.89.e.0" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="withdrawal of PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.90" text="Evaluation of patients with hypertension, heart failure, or myocardial infarction should always include assessment of renal function. "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.91" text="(See DOSAGE AND ADMINISTRATION.)"/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.92" text="Hyperkalemia: In clinical trials hyperkalemia (serum potassium greater than 5.7 mEq/L) occurred in approximately 2.2 percent of hypertensive patients and 4.8 percent of patients with heart failure. "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.93" text="In most cases these were isolated values which resolved despite continued therapy. "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.94" text="Hyperkalemia was a cause of discontinuation of therapy in approximately 0.1 percent of hypertensive patients, 0.6 percent of patients with heart failure and 0.1 percent of patients with myocardial infarction. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97" lineNumber="80" text="PRINIVIL should be used cautiously, if at all, with these agents and with frequent monitoring of serum potassium. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="52:64" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.0" text="these agents" type="Expression"/><antecedentEntity charOffset="124:151" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.2" text="potassium-sparing diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="52:64" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.0" text="these agents" type="Expression"/><antecedentEntity charOffset="153:174" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.3" text="potassium supplements" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95" Text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes. "/><anaphoraEntity charOffset="52:64" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.0" text="these agents" type="Expression"/><antecedentEntity charOffset="182:219" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.95.e.4" text="potassium-containing salt substitutes" type="Substance"/></anaphoraRelation><entity charOffset="19:34" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.4" text="used cautiously" type="Caution_Interaction"/><entity charOffset="0:8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.6" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.6" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.97.e.4" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101" lineNumber="84" text="Surgery/Anesthesia: In patients undergoing major surgery or during anesthesia with agents that produce hypotension, PRINIVIL may block angiotensin II formation secondary to compensatory renin release. " type="regular"><entity charOffset="186:199" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.0" text="renin release" type="Specific_Interaction"/><entity charOffset="116:124" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.2" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="83:114" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.3" text="agents that produce hypotension" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="67:77" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.4" text="anesthesia" type="SPAN"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.4" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.2" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.101.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104" text="Angioedema: Angioedema, including laryngeal edema, may occur at any time during treatment with angiotensin converting enzyme inhibitors, including lisinopril. " type="negative"><entity charOffset="95:135" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with angiotensin converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="147:157" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111" lineNumber="94" text="Hyperkalemia: Patients should be told not to use salt substitutes containing potassium without consulting their physician." type="irregular"><entity charOffset="38:48" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.e.0" text="not to use" type="Caution_Interaction"/><entity charOffset="49:86" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.e.2" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104" text="Angioedema: Angioedema, including laryngeal edema, may occur at any time during treatment with angiotensin converting enzyme inhibitors, including lisinopril. "><entity charOffset="147:157" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.104.e.0" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.105" text="Patients should be so advised and told to report immediately any signs or symptoms suggesting angioedema (swelling of face, extremities, eyes, lips, tongue, difficulty in swallowing or breathing) and to take no more drug until they have consulted with the prescribing physician."/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.106" text="Symptomatic Hypotension: Patients should be cautioned to report lightheadedness especially during the first few days of therapy. "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.107" text="If actual syncope occurs, the patients should be told to discontinue the drug until they have consulted with the prescribing physician."/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.108" text="All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in blood pressure because of reduction in fluid volume. "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.109" text="Other causes of volume depletion such as vomiting or diarrhea may also lead to a fall in blood pressure; "/><middleSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.110" text="patients should be advised to consult with their physician."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.111.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112" lineNumber="96" text="Hypoglycemia: Diabetic patients treated with oral antidiabetic agents or insulin starting an ACE inhibitor should be told to closely monitor for hypoglycemia, especially during the first month of combined use. " type="regular"><entity charOffset="133:140" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="14:31" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.2" text="Diabetic patients" type="SPAN"/><entity charOffset="45:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.3" text="oral antidiabetic agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="treated with oral antidiabetic agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="73:80" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="93:106" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.5" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="an ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.2" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.4" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.5" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.0" type="Caution_Interaction"/><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.2" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.5" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.112.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119" lineNumber="104" text="Hypotension - Patients on Diuretic Therapy: Patients on diuretics, and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with PRINIVIL. " type="regular"><entity charOffset="179:206" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.0" text="reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="96:104" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.2" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="those in whom diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="240:248" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.3" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="with PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.119.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120" text="The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL. " type="negative"><entity charOffset="44:52" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="98:106" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="175:183" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.2" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="with PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.120.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.121" text="If it is necessary to continue the diuretic, initiate therapy with PRINIVIL at a dose of 5 mg daily, and provide close medical supervision after the initial dose until blood pressure has stabilized. " type="negative"><entity charOffset="67:75" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.121.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="therapy with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="35:43" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.121.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.121.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.121.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123" lineNumber="104" text="When a diuretic is added to the therapy of a patient receiving PRINIVIL, an additional antihypertensive effect is usually observed. " type="regular"><entity charOffset="87:110" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.0" text="antihypertensive effect" type="Specific_Interaction"/><entity charOffset="7:15" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.2" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.3" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="added to the therapy of a patient receiving PRINIVIL," preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.0"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.123.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124" text="Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic. " type="negative"><entity charOffset="48:57" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="88:101" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the dose of the ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="141:149" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.2" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="given with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="13:27" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.3" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Studies with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.2"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.124.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126" lineNumber="106" text="Antidiabetics: Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased blood-glucose-lowering effect with risk of hypoglycemia. " type="regular"><entity charOffset="89:103" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="that concomitant administration of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="108:130" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.1" text="antidiabetic medicines" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="antidiabetic medicines" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C0013227" phraseText="antidiabetic medicines" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="132:140" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.2" text="insulins" type="Drug_Class"><Normalization><mmtx cui="C0021641" phraseText="(insulins," preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C3537244" phraseText="(insulins," preferredWord="Insulins" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="142:166" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.3" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="191:213" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.6" text="blood-glucose-lowering" type="Specific_Interaction"/><entity charOffset="234:246" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.8" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="an increased blood-glucose-lowering effect with risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/><mmtx cui="C0020615" phraseText="an increased blood-glucose-lowering effect with risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.1"/><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.2"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.6"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.ddi.2"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.8"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.1" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.126.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128" lineNumber="106" text="In diabetic patients treated with oral antidiabetic agents or insulin, glycemic control should be closely monitored for hypoglycemia, especially during the first month of treatment with an ACE inhibitor." type="regular"><entity charOffset="189:202" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.0" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with an ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="106:115" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="34:58" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.3" text="oral antidiabetic agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="treated with oral antidiabetic agents" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin," preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin," preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin," preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.4" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.128.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129" lineNumber="108" text="Non-steroidal Anti-inflammatory Agents Including Selective Cyclooxygenase-2 (COX-2) Inhibitors: Reports suggest that NSAIDs including selective COX-2 inhibitors may diminish the antihypertensive effect of ACE inhibitors, including lisinopril. " type="regular"><entity charOffset="205:219" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the antihypertensive effect of ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="231:241" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.1" text="lisinopril" type="Drug"><Normalization><mmtx cui="C0065374" phraseText="lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><entity charOffset="117:123" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="that NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="134:160" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="165:201" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.6" text="diminish the antihypertensive effect" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.1" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.0"/><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.4"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.129.e.6" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130" text="This interaction should be given consideration in patients taking NSAIDs or selective COX-2 inhibitors concomitantly with ACE inhibitors." type="negative"><entity charOffset="86:102" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.0" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors concomitantly with ACE inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="92:125" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.1" text="inhibitors ace" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="selective COX-2 inhibitors concomitantly with ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="66:72" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.2" text="nsaids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.130.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131" lineNumber="110" text="In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant." type="regular"><entity charOffset="14:25" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.0" text="36 patients" type="SPAN"/><entity charOffset="31:60" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.1" text="mild to moderate hypertension" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="with mild to moderate hypertension where" preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><entity charOffset="131:139" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.2" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="compared to PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="165:177" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.3" text="indomethacin" type="Drug"><Normalization><mmtx cui="C0021246" phraseText="concomitantly with indomethacin," preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="225:256" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.4" text="reduced antihypertensive effect" type="Decrease_Interaction"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.4"><relations><relation type="hasEvidence"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.1" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.3" evidence="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.131.e.4" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132" lineNumber="112" text="In some patients with compromised renal function (e.g., elderly patients or patients who are volume-depleted including those on diuretic therapy) who are being treated with non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors, the co-administration of angiotensin II receptor antagonists or ACE inhibitors may result in a further deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="314:328" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="173:210" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.1" text="non-steroidal anti-inflammatory drugs" type="Drug_Class"><Normalization><mmtx cui="C3536840" phraseText="treated with non-steroidal anti-inflammatory drugs," preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="222:248" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="22:48" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.4" text="compromised renal function" type="SPAN"/><entity charOffset="353:384" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.5" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="405:424" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.7" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.2"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.ddi.2"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.4" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.132.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134" lineNumber="114" text="These interactions should be considered in patients taking NSAIDS including selective COX-2 inhibitors concomitantly with diuretics and angiotensin II antagonists or ACE inhibitors. " type="regular"><entity charOffset="6:39" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.0" text="interactions should be considered" type="Caution_Interaction"/><entity charOffset="59:65" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.2" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="76:102" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.3" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors concomitantly with diuretics" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="122:131" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.5" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="selective COX-2 inhibitors concomitantly with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="166:180" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.6" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.3"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.5" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.6" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.6" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.134.e.5"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136" lineNumber="116" text="Dual Blockade of the Renin-angiotensin-aldosterone System: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) with angiotensin receptor blockers, ACE inhibitors, or direct renin inhibitors (such as aliskiren) is associated with increased risks of hypotension, syncope, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="regular"><entity charOffset="160:174" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="129:158" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="179:202" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2" text="direct renin inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1950687" phraseText="direct renin inhibitors" preferredWord="DIRECT RENIN INHIBITOR" semType="phsu"/><RxNorm RxCui="3525"/></Normalization></entity><entity charOffset="212:221" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="such as aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="261:272" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.5" text="hypotension" type="Specific_Interaction"/><entity charOffset="274:281" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.7" text="syncope" type="Specific_Interaction"><Normalization><mmtx cui="C0039070" phraseText="syncope," preferredWord="Syncope" semType="sosy"/></Normalization></entity><entity charOffset="283:295" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.9" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="301:326" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.11" text="changes in renal function" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.3" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.ddi.2"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.ddi.3"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.ddi.4"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.11"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.5" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.5" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.136.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137" text="Closely monitor blood pressure, renal function, and electrolytes in patients on PRINIVIL and other agents that affect the RAAS. " type="negative"><entity charOffset="52:64" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolytes in patients" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="122:126" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.1" text="raas" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the RAAS." preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="80:88" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.2" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="on PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.2"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.137.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138" lineNumber="116" text="Do not coadminister aliskiren with PRINIVIL in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="0:19" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.2" text="Do not coadminister" type="SPAN"/><entity charOffset="20:29" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with PRINIVIL" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:43" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="aliskiren with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="61:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.5" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.0"><relations><relation type="hasSeverity"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.5" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.4" severity="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.2" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.138.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139" lineNumber="116" text="Avoid use of aliskiren with PRINIVIL in patients with renal impairment (GFR &lt;60ml/min)." type="regular"><entity charOffset="0:9" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.0" text="Avoid use" type="Caution_Interaction"/><entity charOffset="0:9" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.2" text="Avoid use" type="SPAN"/><entity charOffset="13:22" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:36" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="54:70" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.5" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.0"><relations><relation type="hasSeverity"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.4" severity="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.2" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.139.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.140" text="Other Agents: PRINIVIL has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions. " type="negative"><entity charOffset="72:79" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.140.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin without evidence of clinically significant adverse interactions." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="14:22" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.140.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.140.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.140.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142" text="No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide. " type="negative"><entity charOffset="119:138" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="67:75" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="104:115" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.2" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="concomitantly with propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.142.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144" lineNumber="120" text="Agents Increasing Serum Potassium: PRINIVIL attenuates potassium loss caused by thiazide-type diuretics. " type="regular"><entity charOffset="35:43" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.0" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="55:69" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.1" text="potassium loss" type="Specific_Interaction"/><entity charOffset="80:103" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.3" text="thiazide-type diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide-type diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.144.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145" lineNumber="120" text="Use of PRINIVIL with potassium-sparing diuretics (e.g., spironolactone, eplerenone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. " type="regular"><entity charOffset="7:15" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.0" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="Use of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="21:48" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="with potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="56:70" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="72:82" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.3" text="eplerenone" type="Drug"><Normalization><mmtx cui="C0961485" phraseText="eplerenone," preferredWord="eplerenone" semType="strd, phsu"/><RxNorm RxCui="298869"/></Normalization></entity><entity charOffset="84:95" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.5" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="112:133" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.6" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="138:175" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.7" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="200:228" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.8" text="increases in serum potassium" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.2" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.3" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.4" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.5" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.6" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.7" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.8" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.6"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.6" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.7"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.145.e.7"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147" lineNumber="120" text="Potassium-sparing agents should generally not be used in patients with heart failure who are receiving PRINIVIL." type="regular"><entity charOffset="0:24" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.0" text="Potassium-sparing agents" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="Potassium-sparing agents" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C1254351" phraseText="Potassium-sparing agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="42:53" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="42:53" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.3" text="not be used" type="SPAN"/><entity charOffset="103:111" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="receiving PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="71:84" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.5" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="with heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="with heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.0"/></relation><relation type="hasSeverity"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.5" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.4" severity="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.147.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148" lineNumber="122" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors. " type="regular"><entity charOffset="17:25" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.0" text="toxicity" type="Increase_Interaction"/><entity charOffset="66:73" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium concomitantly with drugs" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="93:132" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.3" text="drugs which cause elimination of sodium" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="lithium concomitantly with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597484" phraseText="elimination of sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="144:158" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><classClassMembership drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.4"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.148.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149" text="Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor. " type="negative"><entity charOffset="0:7" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.0" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="Lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="64:71" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="usually reversible upon discontinuation of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="80:93" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.2" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.2"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.149.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150" text="It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium." type="negative"><entity charOffset="29:36" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.0" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="that serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="71:79" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="115:122" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.2" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="concomitantly with lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.150.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151" lineNumber="124" text="Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including PRINIVIL." type="regular"><anaphoraRelation><anaphoraEntity charOffset="166:187" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.1" text="sodium aurothiomalate" type="Drug"/><antecedentEntity charOffset="149-164" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.0" text="injectable gold" type="Drug"/></anaphoraRelation><entity charOffset="149:164" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.0" text="injectable gold" type="Drug"><Normalization><mmtx cui="C0018026" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="166:187" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.1" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="205:218" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.3" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="237:245" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="6:25" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.6" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="114:120" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.8" text="rarely" type="SPAN"/><drugClassMembership drug="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.4" drugClass="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.3"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.0"/></relation><relation type="hasEvidence"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.3" evidence="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.8" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.151.e.6" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.159" text="There were no adverse effects on reproductive performance in male and female rats treated with up to 300 mg/kg/day of lisinopril (33 times the MRHDD when compared on a body surface area basis)." type="negative"><entity charOffset="186:191" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.159.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a body surface area basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="118:128" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.159.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="of lisinopril" preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.159.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.159.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.161" text="Milk of lactating rats contains radioactivity following administration of 14C lisinopril. " type="negative"><entity charOffset="8:17" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.161.e.0" text="lactating" type="Biomedical_Entity"><Normalization><mmtx cui="C0376261" phraseText="Milk of lactating rats" preferredWord="Lactate" semType="phsu, orch"/><RxNorm RxCui="114202"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.161.e.1" text="lisinopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0065374" phraseText="administration of 14C lisinopril." preferredWord="Lisinopril" semType="phsu, aapp"/><RxNorm RxCui="29046"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.161.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.161.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.163" text="Because many drugs are secreted in human milk, and because of the potential for serious adverse reactions in nursing infants from ACE inhibitors, a decision should be made whether to discontinue nursing or discontinue PRINIVIL, taking into account the importance of the drug to the mother." type="negative"><entity charOffset="130:144" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.163.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="from ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="218:226" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.163.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL," preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.163.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.163.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.169" text="Antihypertensive effects of PRINIVIL have been established in hypertensive pediatric patients aged 6 to 16 years." type="negative"><entity charOffset="28:36" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.169.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="Antihypertensive effects of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="0:16" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.169.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="Antihypertensive effects of PRINIVIL" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.169.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.169.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.170" text="There are no data on the effect of PRINIVIL on blood pressure in pediatric patients under the age of 6 or in pediatric patients with glomerular filtration rate &lt;30 mL/min/1.73 m2 (see CLINICAL PHARMACOLOGY, Pharmacokinetics and Metabolism and Pharmacodynamics and Clinical Effects, and DOSAGE AND ADMINISTRATION)." type="negative"><entity charOffset="35:43" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.170.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="no data on the effect of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="10:17" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.170.e.1" text="no data" type="Biomedical_Entity"><Normalization><mmtx cui="C1572381" phraseText="no data on the effect of PRINIVIL" preferredWord="No Data re: Ingredient" semType="phsu"/><RxNorm RxCui="53704"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.170.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.170.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192" text="If blood pressure is not controlled with PRINIVIL alone, a low dose of a diuretic may be added. " type="negative"><entity charOffset="73:81" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a low dose of a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="41:49" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="controlled with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193" lineNumber="164" text="Hydrochlorothiazide 12.5 mg has been shown to provide an additive effect. " type="irregular"><entity charOffset="0:19" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0986524" phraseText="Hydrochlorothiazide 12.5 mg" preferredWord="Hydrochlorothiazide 12.5 MG" semType="clnd"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="57:72" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.e.1" text="additive effect" type="Increase_Interaction"/><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192" text="If blood pressure is not controlled with PRINIVIL alone, a low dose of a diuretic may be added. "><entity charOffset="41:49" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.192.e.0" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="controlled with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.193.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.194" text="After the addition of a diuretic, it may be possible to reduce the dose of PRINIVIL." type="negative"><entity charOffset="75:83" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.194.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="the dose of PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="24:32" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.194.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="of a diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.194.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.194.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195" lineNumber="166" text="Diuretic Treated Patients: In hypertensive patients who are currently being treated with a diuretic, symptomatic hypotension may occur occasionally following the initial dose of PRINIVIL. " type="regular"><entity charOffset="113:124" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="30:51" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.2" text="hypertensive patients" type="SPAN"/><entity charOffset="91:99" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with a diuretic, symptomatic hypotension" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="178:186" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.4" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="the initial dose of PRINIVIL." preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.0"><relations><relation type="hasContext"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.2" ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.4" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.195.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.196" text="The diuretic should be discontinued, if possible, for two to three days before beginning therapy with PRINIVIL to reduce the likelihood of hypotension. " type="negative"><entity charOffset="102:110" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.196.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="with PRINIVIL to" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="4:12" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.196.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="The diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.196.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.196.e.0"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.199" text="If the patient's blood pressure is not controlled with PRINIVIL alone, diuretic therapy may be resumed as described above." type="negative"><entity charOffset="55:63" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.199.e.0" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="controlled with PRINIVIL alone, diuretic therapy" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="71:79" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.199.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="controlled with PRINIVIL alone, diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.199.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.199.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.200" text="If the diuretic cannot be discontinued, an initial dose of 5 mg should be used under medical supervision for at least two hours and until blood pressure has stabilized for at least an additional hour. " type="negative"><entity charOffset="40:60" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.200.e.0" text="an 5" type="Biomedical_Entity"><Normalization><mmtx cui="C0526789" phraseText="an initial dose of 5 mg" preferredWord="AN(5)" semType="phsu, orch"/><RxNorm RxCui="707263"/></Normalization></entity><entity charOffset="7:15" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.200.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.200.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.200.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202" lineNumber="170" text="Concomitant administration of PRINIVIL with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics may lead to increases of serum potassium (see PRECAUTIONS)." type="regular"><entity charOffset="139:166" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.0" text="ncreases of serum potassium" type="Specific_Interaction"/><entity charOffset="30:38" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.2" text="PRINIVIL" type="Drug"><Normalization><mmtx cui="C0701176" phraseText="Concomitant administration of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="44:65" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.3" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="with potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="67:93" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.4" text="potassium salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="98:125" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.5" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><drugInteraction id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.ddi.1"><interaction trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.4" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.3" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.5" trigger="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.4"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.4" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.5"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.3" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.202.e.5"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208" text="PRINIVIL is indicated as adjunctive therapy with diuretics and (usually) digitalis. " type="negative"><entity charOffset="73:82" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis." preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><entity charOffset="49:58" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.2" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.0"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.208.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.217" text="Dosage Adjustment in Patients with Heart Failure and Renal Impairment or Hyponatremia: In patients with heart failure who have hyponatremia (serum sodium less than 130 mEq/L) or moderate to severe renal impairment (creatinine clearance less than or equal to 30 mL/min or serum creatinine greater than 3 mg/dL), therapy with PRINIVIL should be initiated at a dose of 2.5 mg once a day under close medical supervision. " type="negative"><entity charOffset="147:153" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.217.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="(serum sodium less than 130 mEq/" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="324:332" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.217.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="therapy with PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.217.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.217.e.1"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222" text="Patients should receive, as appropriate, the standard recommended treatments such as thrombolytics, aspirin and beta-blockers. " type="negative"><entity charOffset="85:98" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.0" text="thrombolytics" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="the standard recommended treatments such as thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><entity charOffset="100:107" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="112:125" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.2" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.1"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.2"/><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.1" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.222.e.2"/></sentence><sentence id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.239" text="Add 10 mL of Purified Water USP to a polyethylene terephthalate (PET) bottle containing ten 20-mg tablets of PRINIVIL and shake for at least one minute. " type="negative"><entity charOffset="13:27" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.239.e.0" text="purified water" type="Biomedical_Entity"><Normalization><mmtx cui="C0991883" phraseText="10 mL of Purified Water USP" preferredWord="purified water" semType="inch, phsu"/><RxNorm RxCui="223280"/></Normalization></entity><entity charOffset="109:117" id="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.239.e.1" text="prinivil" type="Biomedical_Entity"><Normalization><mmtx cui="C0701176" phraseText="of PRINIVIL" preferredWord="Prinivil" semType="phsu, aapp"/><RxNorm RxCui="203644"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.239.e.0" e2="Dailymed.f6f3c339-2c9d-4d07-14a1-6d6c7daf26c6.s.239.e.1"/></sentence><positiveExamples number="41"/><negativeExamples number="79"/></document>